Caribou Biosciences, Inc. (CRBU) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Caribou Biosciences, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBU
Caribou Biosciences, Inc.
$1.19HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
LUCD
Lucid Diagnostics Inc.
$0.61HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — CRBU vs LUCD
growth of $100 · dividends reinvested · last 5yCRBU -94.7% (-44.5%/yr)LUCD -95.0% (-45.0%/yr)CRBU compounded faster over this window
CRBU LUCD
CRBU vs LUCD: by the numbers
- •CRBU is the larger company ($118M vs $116M market cap).
- •Both run net losses; LUCD's is the smaller (-959.76% vs -1030.42% net margin).
Metrics side by side
Valuation
| Metric | CRBU | LUCD |
|---|---|---|
| P/S ratio | 11.71 | 21.38 |
| P/B ratio | 1.20 | 10.66 |
Profitability
| Metric | CRBU | LUCD |
|---|---|---|
| Gross margin | 67.34% | -60.26% |
| Operating margin | -1220.49% | -1054.82% |
| Net margin | -1030.42% | -959.76% |
| ROE | -105.40% | -478.26% |
| ROIC | -87.72% | -145.10% |
Growth (annualized)
| Metric | CRBU | LUCD |
|---|---|---|
| Revenue CAGR (5Y) | -2.03% | N/A |
| Total return CAGR (5Y) | -44.43% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.